EUR 102.1
(0.79%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 1.5 Billion EUR | -2.37% |
2022 | 1.54 Billion EUR | 7.1% |
2021 | 1.44 Billion EUR | -0.35% |
2020 | 1.44 Billion EUR | -5.29% |
2019 | 1.52 Billion EUR | 1.66% |
2018 | 1.5 Billion EUR | 19.88% |
2017 | 1.25 Billion EUR | -10.96% |
2016 | 1.4 Billion EUR | 10.74% |
2015 | 1.27 Billion EUR | 6.65% |
2014 | 1.19 Billion EUR | 28.25% |
2013 | 929.3 Million EUR | 46.81% |
2012 | 633 Million EUR | -3.92% |
2011 | 658.8 Million EUR | 39.4% |
2010 | 472.6 Million EUR | 4.26% |
2009 | 453.3 Million EUR | -9.48% |
2008 | 500.8 Million EUR | 26.11% |
2007 | 397.1 Million EUR | 3.93% |
2006 | 382.1 Million EUR | -6.26% |
2005 | 407.6 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 1.43 Billion EUR | 0.0% |
2023 Q2 | 1.38 Billion EUR | 0.0% |
2023 Q4 | 1.5 Billion EUR | 0.0% |
2023 FY | 1.5 Billion EUR | -2.37% |
2022 Q4 | 1.54 Billion EUR | 0.0% |
2022 Q2 | 1.52 Billion EUR | 0.0% |
2022 FY | 1.54 Billion EUR | 7.1% |
2021 Q2 | 1.4 Billion EUR | 0.0% |
2021 Q4 | 1.44 Billion EUR | 0.0% |
2021 FY | 1.44 Billion EUR | -0.35% |
2020 FY | 1.44 Billion EUR | -5.29% |
2020 Q2 | 1.72 Billion EUR | 0.0% |
2020 Q4 | 1.44 Billion EUR | 0.0% |
2019 FY | 1.52 Billion EUR | 1.66% |
2019 Q2 | 1.53 Billion EUR | 0.0% |
2019 Q4 | 1.52 Billion EUR | 0.0% |
2018 FY | 1.5 Billion EUR | 19.88% |
2018 Q2 | 1.16 Billion EUR | 0.0% |
2018 Q4 | 1.5 Billion EUR | 0.0% |
2017 Q4 | 1.25 Billion EUR | 0.0% |
2017 FY | 1.25 Billion EUR | -10.96% |
2017 Q2 | 1.28 Billion EUR | 0.0% |
2016 FY | 1.4 Billion EUR | 10.74% |
2016 Q2 | 1.24 Billion EUR | 0.0% |
2016 Q4 | 1.4 Billion EUR | 0.0% |
2015 Q2 | 1.23 Billion EUR | 0.0% |
2015 FY | 1.27 Billion EUR | 6.65% |
2015 Q4 | 1.27 Billion EUR | 0.0% |
2014 FY | 1.19 Billion EUR | 28.25% |
2014 Q4 | 1.19 Billion EUR | 0.0% |
2014 Q2 | 1.05 Billion EUR | 0.0% |
2013 Q2 | 635.4 Million EUR | 0.0% |
2013 Q4 | 929.3 Million EUR | 0.0% |
2013 FY | 929.3 Million EUR | 46.81% |
2012 FY | 633 Million EUR | -3.92% |
2012 Q4 | 633 Million EUR | 300.0% |
2012 Q3 | 158.25 Million EUR | -75.64% |
2012 Q2 | 649.7 Million EUR | 310.55% |
2012 Q1 | 158.25 Million EUR | -75.98% |
2011 Q3 | 164.7 Million EUR | -65.79% |
2011 FY | 658.8 Million EUR | 39.4% |
2011 Q4 | 658.8 Million EUR | 300.0% |
2011 Q1 | 164.7 Million EUR | -65.15% |
2011 Q2 | 481.4 Million EUR | 192.29% |
2010 Q4 | 472.6 Million EUR | 300.0% |
2010 FY | 472.6 Million EUR | 4.26% |
2010 Q3 | 118.15 Million EUR | -75.16% |
2010 Q2 | 475.6 Million EUR | 302.54% |
2010 Q1 | 118.15 Million EUR | -73.94% |
2009 Q3 | 113.32 Million EUR | 0.0% |
2009 Q4 | 453.3 Million EUR | 300.0% |
2009 FY | 453.3 Million EUR | -9.48% |
2009 Q2 | 113.32 Million EUR | 0.0% |
2009 Q1 | 113.32 Million EUR | -9.48% |
2008 FY | 500.8 Million EUR | 26.11% |
2008 Q4 | 125.2 Million EUR | 0.0% |
2008 Q3 | 125.2 Million EUR | 0.0% |
2008 Q2 | 125.2 Million EUR | 0.0% |
2008 Q1 | 125.2 Million EUR | 26.11% |
2007 FY | 397.1 Million EUR | 3.93% |
2007 Q4 | 99.27 Million EUR | 0.0% |
2007 Q1 | 99.27 Million EUR | 3.93% |
2007 Q2 | 99.27 Million EUR | 0.0% |
2007 Q3 | 99.27 Million EUR | 0.0% |
2006 Q2 | 95.52 Million EUR | 0.0% |
2006 Q1 | 95.52 Million EUR | -6.26% |
2006 FY | 382.1 Million EUR | -6.26% |
2006 Q4 | 95.52 Million EUR | 0.0% |
2006 Q3 | 95.52 Million EUR | 0.0% |
2005 Q2 | 101.9 Million EUR | 0.0% |
2005 Q3 | 101.9 Million EUR | 0.0% |
2005 FY | 407.6 Million EUR | 0.0% |
2005 Q1 | 101.9 Million EUR | 0.0% |
2005 Q4 | 101.9 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Biosynex SA | 117.41 Million EUR | -1183.578% |
Predilife S.A. | 8.3 Million EUR | -18047.004% |
Eurofins Scientific SE | 6.75 Billion EUR | 77.677% |
Lumibird SA | 207.98 Million EUR | -624.634% |